Seranova Bio is an early-stage company dedicated to the creation of groundbreaking therapeutics. Our proprietary REAP (rapid extracellular antigen profiling) technology and analytics platform enable the discovery of the functional immune interactions that drive health and disease. We were founded in 2020 by Fred Hutchinson Cancer Center professor and serial academic entrepreneur Aaron Ring. Located in the vibrant biotech hub of South San Francisco, we are proudly supported by leading investors Foresite Capital Management and The Column Group.
Company Details
- Employees
- 8
- Founded
- -
- Address
- South San Francisco, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.seranovabio.com
- HQ
- South San Francisco, CA
Seranova Bio Questions
Seranova Bio's website is http://www.seranovabio.com
Seranova Bio's LinkedIn profile is https://www.linkedin.com/company/seranova-bio
Seranova Bio has
8 employees.
View email and phone details for 8
employees at Seranova Bio.
Seranova Bio's industry is
Biotechnology Research
Seranova Bio's top competitors are
Seranova,
Simcha Therapeutics,
Octagon Therapeutics,
Ariax Bio,
Hexagon Bio,
Stipple Bio,
Bolden Therapeutics,
Thrive Bioscience, Inc.,
Sonoma Biotherapeutics, Inc.,
Foresite Labs.
Seranova Bio's categories are Biotechnology Research
Seranova Bio's founding year is 2020
